Psoriasiform Drug Eruption Caused by Abatacept: Immunohistochemical Investigation of STAT Signaling

• Autori principali: Kayo Tanita (Autore), Taku Fujimura (Autore), Aya Kakizaki (Autore), Sadanori Furudate (Autore), Yoshiyuki Kusakari (Autore), Setsuya Aiba (Autore)
• Natura: Libro
• Pubblicazione: Karger Publishers, 2015-07-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abatacept is a biological immune modifier that is used for the treatment of rheumatoid arthritis. Although psoriasiform drug eruption is reported as one of the cutaneous adverse effects of abatacept, the precise mechanisms are not fully understood. In this report, we describe a 65-year-old Japanese...